Hypothermia and Neonatal Encephalopathy
Citations Over TimeTop 1% of 2014 papers
Abstract
Data from large randomized clinical trials indicate that therapeutic hypothermia, using either selective head cooling or systemic cooling, is an effective therapy for neonatal encephalopathy. Infants selected for cooling must meet the criteria outlined in published clinical trials. The implementation of cooling needs to be performed at centers that have the capability to manage medically complex infants. Because the majority of infants who have neonatal encephalopathy are born at community hospitals, centers that perform cooling should work with their referring hospitals to implement education programs focused on increasing the awareness and identification of infants at risk for encephalopathy, and the initial clinical management of affected infants.
Related Papers
- → Hypothermia therapy for newborns with hypoxic ischemic encephalopathy(2015)118 cited
- → The Frequency and Severity of Magnetic Resonance Imaging Abnormalities in Infants with Mild Neonatal Encephalopathy(2017)97 cited
- → Unanswered questions regarding therapeutic hypothermia for neonates with neonatal encephalopathy(2021)43 cited
- → Use of Therapeutic Hypothermia for Term Infants with Hypoxic-Ischemic Encephalopathy(2009)33 cited
- → Effects of Therapeutic Hypothermia Initiated After 6 Hours of Age on Death or Disability Among Newborns With Hypoxic-ischemic Encephalopathy(2018)8 cited